- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
State of the States - 2018
This report reflects a complete analysis of medical cannabis programs across the United States, in an effort to objectively evaluate how those programs serve patients. “Medical Marijuana Access in the United States: A Patient-Focused Analysis of the Patchwork of State Laws” has been updated, expanded and refined over the last three years to convey the state of medical cannabis in America, serve as a tool for comparing different laws and regulations, and assign simple letter grades.
Our grading system has not yet awarded an A grade to any state. However, in comparing year to year, we can see a general upward trend in the scores. There are medical cannabis programs of some kind in 46 states, the District of Columbia, and the territories of Guam and Puerto Rico. The highest grade awarded was an 89.8% (B+) to California and the lowest was a 23.4% (F) awarded to Wisconsin.
A development we saw over the last year that had a significant impact in scoring was the implementation of good product safety regulations. Alaska's regulatory improvements for labeling, testing and training brought their program up a letter grade. On the other hand, most drops in score were related to restrictions on access like the Florida Department of Health preventing the use of dried cannabis flowers.
Our last observation takes place in the context of America's opioid crisis. A major area most all states could improve is making medical cannabis a front-line treatment option for those living with pain. West Virginia which passed their law just this year clearly has pain and opioid use as major objectives for it's medical cannabis program. Other state's lawmakers should look to them to see how medical cannabis can help combat this public health crisis.
Download the 2018 Report
Share the 2018 Report
Purchase a printed copy of the report